These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12097415)

  • 1. Characterization of autoreactive T cells to the autoantigens heterogeneous nuclear ribonucleoprotein A2 (RA33) and filaggrin in patients with rheumatoid arthritis.
    Fritsch R; Eselböck D; Skriner K; Jahn-Schmid B; Scheinecker C; Bohle B; Tohidast-Akrad M; Hayer S; Neumüller J; Pinol-Roma S; Smolen JS; Steiner G
    J Immunol; 2002 Jul; 169(2):1068-76. PubMed ID: 12097415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome.
    Zimmermann C; Steiner G; Skriner K; Hassfeld W; Petera P; Smolen JS
    Arthritis Rheum; 1998 Nov; 41(11):1938-45. PubMed ID: 9811047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex.
    Steiner G; Hartmuth K; Skriner K; Maurer-Fogy I; Sinski A; Thalmann E; Hassfeld W; Barta A; Smolen JS
    J Clin Invest; 1992 Sep; 90(3):1061-6. PubMed ID: 1522214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rheumatoid arthritis-associated autoantigen hnRNP-A2 (RA33) is a major stimulator of autoimmunity in rats with pristane-induced arthritis.
    Hoffmann MH; Tuncel J; Skriner K; Tohidast-Akrad M; Türk B; Pinol-Roma S; Serre G; Schett G; Smolen JS; Holmdahl R; Steiner G
    J Immunol; 2007 Dec; 179(11):7568-76. PubMed ID: 18025202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to native and citrullinated RA33 (hnRNP A2/B1) challenge citrullination as the inciting principle underlying loss of tolerance in rheumatoid arthritis.
    Konig MF; Giles JT; Nigrovic PA; Andrade F
    Ann Rheum Dis; 2016 Nov; 75(11):2022-2028. PubMed ID: 26865600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of the autoantigen heterogeneous nuclear ribonucleoprotein-A2 (RA33) and spontaneous formation of rheumatoid arthritis-associated anti-RA33 autoantibodies in TNF-alpha transgenic mice.
    Hayer S; Tohidast-Akrad M; Haralambous S; Jahn-Schmid B; Skriner K; Trembleau S; Dumortier H; Pinol-Roma S; Redlich K; Schett G; Muller S; Kollias G; Smolen J; Steiner G
    J Immunol; 2005 Dec; 175(12):8327-36. PubMed ID: 16339574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease.
    Skriner K; Sommergruber WH; Tremmel V; Fischer I; Barta A; Smolen JS; Steiner G
    J Clin Invest; 1997 Jul; 100(1):127-35. PubMed ID: 9202064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
    Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
    Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-RA33 autoantibodies may recognize epitopes in the N-terminal region of hnRNP-A2 (RA33).
    Skriner K; Steiner G; Sommergruber WH; Sinski A; Smolen JS
    Clin Exp Rheumatol; 1994; 12 Suppl 11():S79-82. PubMed ID: 7539351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunodominant T-cell epitopes of hnRNP-A2 associated with disease activity in patients with rheumatoid arthritis.
    Trembleau S; Hoffmann M; Meyer B; Nell V; Radner H; Zauner W; Hammer J; Aichinger G; Fischer G; Smolen J; Steiner G
    Eur J Immunol; 2010 Jun; 40(6):1795-808. PubMed ID: 20232340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to the A/B proteins of the heterogeneous nuclear ribonucleoprotein complex: novel tools for the diagnosis of rheumatic diseases.
    Steiner G; Skriner K; Smolen JS
    Int Arch Allergy Immunol; 1996 Dec; 111(4):314-9. PubMed ID: 8957102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibody and metalloproteinase activity in early arthritis.
    Ponikowska M; Świerkot J; Nowak B; Korman L; Wiland P
    Clin Rheumatol; 2019 Mar; 38(3):827-834. PubMed ID: 30406565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenic HLA-DR-Presented Self-Peptides Identified Directly from Clinical Samples of Synovial Tissue, Synovial Fluid, or Peripheral Blood in Patients with Rheumatoid Arthritis or Lyme Arthritis.
    Wang Q; Drouin EE; Yao C; Zhang J; Huang Y; Leon DR; Steere AC; Costello CE
    J Proteome Res; 2017 Jan; 16(1):122-136. PubMed ID: 27726376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The immunologic homunculus in rheumatoid arthritis. A new viewpoint of immunopathogenesis in rheumatoid arthritis and therapeutic consequences].
    Bläss S; Engel JM; Burmester GR
    Z Rheumatol; 2001 Feb; 60(1):1-16. PubMed ID: 11263010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of MHC class II/human cartilage glycoprotein-39 complexes in synovia of rheumatoid arthritis patients using complex-specific monoclonal antibodies.
    Steenbakkers PG; Baeten D; Rovers E; Veys EM; Rijnders AW; Meijerink J; De Keyser F; Boots AM
    J Immunol; 2003 Jun; 170(11):5719-27. PubMed ID: 12759455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory effects of atorvastatin on peripheral blood mononuclear cells and synovial fibroblasts in rheumatoid arthritis.
    Blaschke S; Viereck V; Schwarz G; Klinger HM; Guerluek S; Müller GA
    Scand J Rheumatol; 2009; 38(4):235-9. PubMed ID: 19247848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune response to the spliceosome. An immunologic link between rheumatoid arthritis, mixed connective tissue disease, and systemic lupus erythematosus.
    Hassfeld W; Steiner G; Studnicka-Benke A; Skriner K; Graninger W; Fischer I; Smolen JS
    Arthritis Rheum; 1995 Jun; 38(6):777-85. PubMed ID: 7779120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B and T cell responses to the spliceosomal heterogeneous nuclear ribonucleoproteins A2 and B1 in normal and lupus mice.
    Dumortier H; Monneaux F; Jahn-Schmid B; Briand JP; Skriner K; Cohen PL; Smolen JS; Steiner G; Muller S
    J Immunol; 2000 Aug; 165(4):2297-305. PubMed ID: 10925319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of anti-RA33 hnRNP autoantibodies and transient spread to U1-A snRNP complex of spliceosome by idiotypic manipulation with anti-RA33 antibody preparation in mice.
    Steiner G; Shovman O; Skriner K; Gilburd B; Langevitz P; Miholits M; Hoet R; Levy Y; Zandman-Goddard G; Hoefler E; Smolen JS; Shoenfeld Y
    Clin Exp Rheumatol; 2002; 20(4):517-24. PubMed ID: 12180437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus.
    Fritsch-Stork R; Müllegger D; Skriner K; Jahn-Schmid B; Smolen JS; Steiner G
    Arthritis Res Ther; 2006; 8(4):R118. PubMed ID: 16859514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.